Atlas Trials

Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

Clinical trial NCT03772041 · COMPLETED

Trial details

NCT number
NCT03772041
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Congestive Heart Failure
Start date
2019-01-16
Primary completion
2020-07-21
Enrollment
294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.